These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16555497)

  • 41. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
    Aagaard L; Weber CB; Hansen EH
    Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
    Thiessard F; Roux E; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Tubert-Bitter P; Bégaud B
    Drug Saf; 2005; 28(8):731-40. PubMed ID: 16048358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases.
    Cliff-Eribo KO; Sammons H; Choonara I
    Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals.
    Harugeri A; Parthasarathi G; Ramesh M; Guido S; Basavanagowdappa H
    J Postgrad Med; 2011; 57(3):189-95. PubMed ID: 21941055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse drug reactions: physicians' opinions versus a causality assessment method.
    Miremont G; Haramburu F; Bégaud B; Péré JC; Dangoumau J
    Eur J Clin Pharmacol; 1994; 46(4):285-9. PubMed ID: 7957509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probable adverse drug reactions in a rural geriatric nursing home population: a four-year study.
    Cooper JW
    J Am Geriatr Soc; 1996 Feb; 44(2):194-7. PubMed ID: 8576512
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 51. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.
    Patel H; Bell D; Molokhia M; Srishanmuganathan J; Patel M; Car J; Majeed A
    BMC Clin Pharmacol; 2007 Sep; 7():9. PubMed ID: 17894876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females?
    Light KP; Lovell AT; Butt H; Fauvel NJ; Holdcroft A
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):151-60. PubMed ID: 16395661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse drug reactions in a medical ward.
    Wu FL; Yang CC; Shen LJ; Chen CY
    J Formos Med Assoc; 1996 Mar; 95(3):241-6. PubMed ID: 8857258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacy-coordinated, multidisciplinary adverse drug reaction program.
    Swanson KM; Landry JP; Anderson RP
    Top Hosp Pharm Manage; 1992 Jul; 12(2):49-59. PubMed ID: 10136574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.
    Passarelli MC; Jacob-Filho W; Figueras A
    Drugs Aging; 2005; 22(9):767-77. PubMed ID: 16156680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse drug reaction monitoring: knowledge, attitude and practices of medical students and prescribers.
    Rehan HS; Vasudev K; Tripathi CD
    Natl Med J India; 2002; 15(1):24-6. PubMed ID: 11855588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic adverse drug reactions: a case/non-case study in Italy.
    Motola D; Vargiu A; Leone R; Cocci A; Salvo F; Ros B; Meneghelli I; Venegoni M; Cutroneo PM; Vaccheri A; Velo G; Montanaro N
    Eur J Clin Pharmacol; 2007 Jan; 63(1):73-9. PubMed ID: 17119945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of adverse drug reactions among ordinary users of liraglutide on the occasion of drug dispensing in the community pharmacy setting.
    Christensen ST; Bjerrum OJ
    J Patient Saf; 2013 Dec; 9(4):219-23. PubMed ID: 24257065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.